Mayo Clinic Cancer Center-Rochester

Rochester, Minnesota 55905

0 studies enrolling now · 6 studies all time

What they study most

Acute Myeloid Leukemia, Cancer, Advanced Solid Tumors, Glioblastoma, Glioma, H3 K27M, PDAC, PDAC - Pancreatic Ductal Adenocarcinoma, Pancreatic Cancer, Stem Cell Transplantation

Studies at this site

• A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma — Recruiting now
• ONC201 in H3 K27M-mutant Diffuse Glioma Following Radiotherapy (the ACTION Study) — Recruiting now
• Phase 3 Study of Daraxonrasib (RMC-6236) in Patients With Previously Treated Metastatic Pancreatic Ductal Adenocarcinoma (PDAC) — Running, not enrolling
• Efficacy of MT-401 in Patients With AML Following Stem Cell Transplant — Stopped early
• A Study of BBI503 in Adult Patients With Advanced Solid Tumors — Completed
• Study of Nanoliposomal Irinotecan (Nal-IRI)-Containing Regimens Versus Nab-paclitaxel Plus Gemcitabine in Patients With Previously Untreated, Metastatic Pancreatic Adenocarcinoma — Completed